BOSTON SCIENTIFIC CORP (NYSE:BSX) was identified by our screener as a strong growth stock with a favorable technical setup. The company combines solid fundamental growth metrics with a bullish chart pattern, making it an interesting candidate for investors seeking growth opportunities.
Fundamental Strengths
Growth: BSX has demonstrated strong revenue and earnings growth, with revenue increasing by 19.35% over the past year and earnings per share (EPS) growing by 26.17%. Future estimates suggest continued growth, with EPS expected to rise by 12.15% annually.
Profitability: The company scores 8/10 in profitability, with strong margins—operating margin at 18.78% and profit margin at 11.58%, outperforming most peers in the Health Care Equipment & Supplies industry.
Financial Health: While liquidity metrics are weaker, BSX maintains a solid solvency position with a healthy Altman-Z score of 6.07 and a manageable debt-to-equity ratio of 0.47.
Technical Setup
Trend Strength: Both short-term and long-term trends are positive, with the stock trading near its 52-week high.
Bull Flag Pattern: BSX is currently forming a bull flag, a continuation pattern that often precedes further upside.
Support & Resistance: Key support levels are found near $93.35 and $91.48, while resistance sits between $104.65 and $106.66. A breakout above this zone could signal further gains.
Recent Momentum: The stock has shown a pocket pivot signal, indicating accumulation by institutional buyers.
This is not investing advice! The article highlights observations at the time of writing, but you should always conduct your own analysis before making investment decisions.
Boston Scientific Corp (NYSE:BSX) combines strong earnings momentum, expanding margins, and a bullish technical setup, making it a candidate for high-growth investors.